Scientists use advanced scanners to peek at Brain's chemical messengers
NCT ID NCT00109174
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 8 times
Summary
This study uses magnetic resonance spectroscopy (MRS) to measure how the brain processes glucose into key chemical messengers like glutamate and GABA. Researchers aim to improve the accuracy and reliability of MRS technology. The study involves 200 healthy adults aged 18-65 and focuses on refining imaging methods rather than testing a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors measure brain chemistry, helping future research on brain disorders.
- What could go wrong
- This is an early-stage observational study in healthy volunteers, not testing a treatment. It may not directly lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NORMAL PHYSIOLOGY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your pupils reveal how light shapes sleep—and why age and sex matter
- Healthy donors needed for research sample bank
- Nicotine's brain impact on depression under the microscope
- Scientists lock volunteers in rooms to measure how many calories they burn after eating
- Brain test could revolutionize alcohol addiction treatment
- Healthy brains scanned twice to test reliability of imaging methods